Early-onset Dementia

Gene: ALS2

Red List (low evidence)

ALS2 (ALS2, alsin Rho guanine nucleotide exchange factor)
EnsemblGeneIds (GRCh38): ENSG00000003393
EnsemblGeneIds (GRCh37): ENSG00000003393
OMIM: 606352, Gene2Phenotype
ALS2 is in 11 panels

1 review

Bryony Thompson (Royal Melbourne Hospital)

Red List (low evidence)

Cognition is reportedly unaffected in individuals with biallelic mutations that have been diagnosed with ALS. One missense VUS has been reported in a case with FTD. Limitied evidence that dementia or cognitive decline is a feature of the conditions caused by this gene.
Created: 5 Feb 2020, 6:04 a.m. | Last Modified: 5 Feb 2020, 6:04 a.m.
Panel Version: 0.1

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Amyotrophic lateral sclerosis 2, juvenile MIM#205100; Primary lateral sclerosis, juvenile MIM#606353; Spastic paralysis, infantile onset ascending MIM#607225

Publications

History Filter Activity

21 Aug 2023, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: als2 has been classified as Red List (Low Evidence).

6 Feb 2020, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: als2 has been classified as Red List (Low Evidence).

6 Feb 2020, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: als2 has been classified as Red List (Low Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: ALS2 was added gene: ALS2 was added to Early-onset Dementia_MGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Complex Neurology Flagship Mode of inheritance for gene: ALS2 was set to Unknown